Table 5. Clinical manifestations and laboratory findings from hospitalized children infected with HAdV-3 and HAdV-7 in seasonal peaks, 2012–2013.
| Characteristic | HAdV-3 (n = 40) | HAdV-7 (n = 16) | p |
|---|---|---|---|
| Age (years) | |||
| 0–3 | 33 (82.5) | 11 (68.8) | 0.257* |
| >3 | 7 (17.5) | 5 (31.2) | |
| Sex (male, %) | 29 (72.5) | 12 (75.0) | 0.849 |
| Underlying diseases (%) | 9 (22.5) | 3 (18.8) | 0.757 |
| Symptom and signs | |||
| Cough | 38 (95.0) | 15 (93.8) | 0.851 |
| Dyspnea | 30 (75.0) | 14 (87.5) | 0.303 |
| Diarrhea | 5 (12.5) | 3 (18.8) | 0.546 |
| Moist rale | 21 (52.5) | 8 (50.0) | 0.866 |
| Laboratory tests | |||
| White blood cell (109/L) | 9.0±3.9 | 7.6±3.1 | 0.201 |
| Neutrophils (%) | 49.8±16.2 | 40.3±20.7 | 0.074 |
| Lymphocyte (%) | 41.6±15.1 | 47.3±18.5 | 0.240 |
| HGB (g/L) | 107±14.5 | 111±14.7 | 0.325 |
| PLT (109/L) | 345±123 | 269±86 | 0.029 |
| Outcome | |||
| Severe pneumonia | 7 (17.5) | 4 (25.0) | 0.523 |
* p value between the HAdV-3 and HAdV-7-positive groups of all ages.